You just read:

Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals Partner to Investigate Metreleptin as Potential Therapy to Improve Blood Glucose Control in Type 1 Diabetes

News provided by

Juvenile Diabetes Research Foundation

Nov 16, 2010, 08:00 ET